Full-Time

Account Sales Representative

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Compensation Overview

$90k - $100k/yr

+ Quarterly Commissions + Car Allowance + Restricted Stock Units (RSUs)

Junior, Mid

Company Historically Provides H1B Sponsorship

Washington, DC, USA

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Customer Service
Requirements
  • Bachelor’s degree or equivalent
  • Minimum of 2 years of sales experience
  • Background in medical or biological sciences preferred
Responsibilities
  • Support CFS with a focus on closing business
  • Work with assigned CFS to maintain & support existing customers
  • Assess the needs of medical professionals and staff members with a focus on customer support, coordination of logistics, and problem-solving
  • Promote quality client/patient relations and create a supportive climate by serving as a role model for other employees
  • Respect and maintain the confidentiality of laboratory and financial information
  • Practice and adhere to all company policies and regulations
  • Follow Compliance procedures and participates in Compliance training
  • Perform miscellaneous duties with completion in a designated time frame
  • Communicate with Natera staff and its customer to ensure quality
  • Maintain and support a service oriented relationship with customers
  • Utilize personal and professional skills to promote excellent customer service
Desired Qualifications
  • Proven track record of success in achieving and exceeding sales goals
  • Award winning sales professional due to individual achievements
  • Exceptionally bright, flexible, self-motivated, and results oriented with strong interpersonal and analytical skills
  • Ability to think strategically as well as execute tactically
  • Must act with a sense of urgency
  • Have a strong desire to work in a startup environment and must work independently with an internal drive to be successful
  • Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and external customers
  • Effective time management skills required with a demonstrated ability to assess and prioritize
  • Proficient in Microsoft PowerPoint and Excel; Gmail; Sales Force.com

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology, cell-free DNA (cfDNA) testing, analyzes DNA fragments in the blood to detect minimal traces of cancer and assess the health of transplanted organs. Natera stands out by offering specialized tests and genetic counseling services directly to healthcare providers and patients, generating revenue through testing kits and services often covered by insurance. The company's goal is to improve patient care through precise genetic insights that support informed medical decisions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for personalized medicine supports Natera's genetic testing services.
  • The global NIPT market is expected to reach $7.3 billion by 2025.
  • Increased adoption of liquid biopsy tests aligns with Natera's cfDNA focus.

What critics are saying

  • Expansion into new Austin space could strain financial resources.
  • Increased competition from companies like Lantheus Holdings threatens market share.
  • HEROES trial for breast cancer may face regulatory hurdles or delays.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for diverse medical applications.
  • Their Signatera test offers personalized ctDNA analysis for cancer patients.
  • Natera's Panorama NIPT has conducted over 2 million non-invasive prenatal tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

5%
PRWeb
May 30th, 2025
The Melanoma Research Foundation To Host The Denver Miles For Melanoma 5K

The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting our annual Denver event on Saturday, June 14, 2025 at Sloan Lake Park at 7:30 AM MT. Opening Ceremonies will start at 8:30 AM MT and our race will kick off promptly at 9:00 AM MT. We are excited to share that Kyle Speller, PA Announcer for the Denver Nuggets, will be returning as our emcee on event day! We're also excited to welcome back local sponsor, Cara Mia Dermatology, who will be providing free on-site skin screenings—helping our community stay sun-safe while supporting a great cause.DENVER, May 29, 2025 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be hosting our annual Denver event on Saturday, June 14, 2025 at Sloan Lake Park at 7:30 AM MT. Opening Ceremonies will start at 8:30 AM MT and our race will kick off promptly at 9:00 AM MT

Intelligence360
May 15th, 2025
Natera To Spend $9.9 Million To Occupy 30,000 Square Feet Of Space In Austin Texas.

Natera to spend $9.9 Million to occupy 30,000 square feet of space in Austin Texas. Natera to spend $9.9 Million to occupy 30,000 square feet of space in Austin Texas.Austin, Texas — According to state and local development sources, Natera plans to invest $9,900,000.00 to build out 30,000 square feet of new space in Austin. The company plans to occupy the new space at 13011A McCallen Pass in Austin, on or about January 1, 2026. According to the company website Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, womens health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment

TXBN
Apr 24th, 2025
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera(TM) Genome MRD Test

Natera announces broad clinical launch of ultra-sensitive signatera(tm) genome MRD test.

Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.